Immunosuppressant-like effects of phenylbutyrate on growth inhibition of Saccharomyces cerevisiae

Current Genetics

Volumn 41, Issue 3, 2002, Pages 142-149

  Grzanowski, Andrew ^a   Needleman, Richard ^a   Brusilow, William S A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BUL1; Phenylbutyrate; Saccharomyces cerevisiae; TAT

Indexed keywords

4 PHENYLBUTYRIC ACID; AROMATIC AMINO ACID; IMMUNOSUPPRESSIVE AGENT; PERMEASE; PHENYLACETIC ACID; PHYTOSPHINGOSINE; RAPAMYCIN; TACROLIMUS; TRANSACTIVATOR PROTEIN; TRYPTOPHAN;

AMINO ACID TRANSPORT; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUXOTROPHY; CANCER THERAPY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DELETION MUTANT; DRUG ACTIVITY; DRUG RESISTANCE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUNGUS MUTANT; GENE DISRUPTION; GENE OVEREXPRESSION; GENE THERAPY; GROWTH INHIBITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; TARGET CELL; TRYPTOPHAN METABOLISM; YEAST CELL;

CLONING, MOLECULAR; DRUG RESISTANCE, MICROBIAL; GENES, FUNGAL; IMMUNOSUPPRESSIVE AGENTS; PHENYLBUTYRATES; PROTEIN BIOSYNTHESIS; SACCHAROMYCES CEREVISIAE; TRANSFORMATION, GENETIC; TRYPTOPHAN;

FUNGI; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0036947243     PISSN: 01728083     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00294-002-0292-0     Document Type: Article

References (35)

1. Adams A, Gottschling DE, Kaiser CA, Stearns T (1997) Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
2. Bar-Ner M, Thibault A, Tsokos M, Magrath IT, Samid D (1999) Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells. Clin Cancer Res 5:1509-1516
3. Carducci MA, Nelson JB, Chan-Tack KM, Ayyagari SR, Sweatt WH, Campbell PA, Nelson WG, Simons JW (1996) Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res 2:379-387
4. Danesi R, Nardini D, Basolo F, Del Tacca M, Samid D, Myers CE (1996) Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene. Mol Pharmacol 49:972-979
5. DiGiuseppe JA, Weng LJ, Yu KH, Fu S, Kastan MB, Samid D, Gore SD (1999) Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis. Leukemia 13:1243-1253
6. Dolinski K, Muir S, Cardenas M, Heitman J (1997) All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 94:13093-13098
7. Dover GJ (1998) Hemoglobin switching protocols in thalassemia. Experience with sodium phenylbutyrate and hydroxyurea. Ann N Y Acad Sci 850:80-86
8. Dover GJ, Brusilow S, Samid D (1992) Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate [letter]. N Engl J Med 327:569-570
9. Dover GJ, Brusilow S, Charache S (1994) Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84:339-343
10. Engelhard HH, Homer RJ, Duncan HA, Rozental J (1998) Inhibitory effects of phenylbutyrate on the proliferation, morphology, migration and invasiveness of malignant glioma cells. J Neurooncol 37:97-108
11. Gore SD, Samid D, Weng LJ (1997) Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells. Clin Cancer Res 3:1755-1762
12. Gorospe M, Shack S, Guyton KZ, Samid D, Holbrook NJ (1996) Up-regulation and functional role of p2lWaf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate. Cell Growth Differ 7:1609
13. Heitman J, Koller A, Kunz J, Henriquez R, Schmidt A, Movva NR, Hall MN (1993) The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae. Mol Cell Biol 13:5010-5019
14. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, et al (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
15. Hoffman CS, Winston F (1987) A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272
16. Huang Y, Waxman S (1998) Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate. Cliti Cancer Res 4:2503-2509
17. Lea MA, Randolph VM (1998) Induction of reporter gene expression by inhibitors of histone deacetylase. Anticancer Res 18:2717-2722
18. Lea MA, Tulsyan N (1995) Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase. Anticancer Res 15:879-883
19. Lea MA, Randolph VM, Hodge SK (1999) Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs. Anticancer Res 19:1971-1976
20. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Myer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DEJ, Hartwell LH, Brown PO, Friend SL (1998) Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4:1293-1301
21. Melchior SW, Brown LG, Figg WD, Quinn JE, Santucci RA, Brunner J, Thuroff JW, Lange PH, Vessella RL (1999) Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo. Int J Oncol 14:501-508
22. Myers AM, Tzagoloff A, Kinney DM, Lusty CJ (1986) Yeast shuttle and integrative vectors with multiple cloning sites suitable for construction of lacZ fusions. Gene 45:299-310
23. Pineau T, Hudgins WR, Liu L, Chen LC, Sher T, Gonzalez FJ, Samid D (1996) Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs. Biochem Pharmacol 52:659-667
24. Piscitelli SC, Thibault A, Figg WD, Tompkins A, Headlee D, Lieberman R, Samid D, Myers CE (1995) Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine. J Clin Pharmacol 35:368-373
25. Regenberg B, During-Olsen L, Kielland-Brandt MC, Holmberg S (1999) Substrate specificity and gene expression of the aminoacid permeases in Saccharomyces cerevisiae. Curr Genet 36:317-328
26. Rolfes RJ, Hinnebusch AG (1993) Translation of the yeast transcriptional activator GCN4 is stimulated by purine limitation: implications for activation of the protein kinase GCN2. Mol Cell Biol 13:5099-6011
27. Rose MD, Novick P, Thomas JH, Botstein D, Fink GR (1987) A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene 60:237-243
28. Samid D, Shack S, Sherman LT (1992a) Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res 52:1988-1992
29. Samid D, Yeh A, Prasanna P (1992b) Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood 80:1576-1581
30. Samid D, Hudgins WR, Shack S, Liu L, Prasanna P, Myers CE (1997) Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers. Adv Exp Med Biol 148:501-505
31. Schmidt A, Hall MN, Koller A (1994) Two FK506 resistance-conferring genes in Saccharomyces cerevisiae, TAT1 and TAT2, encode amino acid permeases mediating tyrosine and tryptophan uptake. Mol Cell Biol 14:6597-6606
32. Shack S, Miller A, Liu L, Prasanna P, Thibault A, Samid D (1996) Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate. Clin Cancer Res 2:865-872
33. Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27
34. Skrzypek MS, Nagiec MM, Lester RL, Dickson RC (1998) Inhibition of amino acid transport by sphingoid long chain bases in Saccharomyces cerevisiae. J Biol Chem 273:2829-2834
35. Warrell RP Jr, He LZ, Richon V. Calleja E, Pandolfi PP (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90:1621-1625